Who owns ADAP?
No institutional manager reported a Adaptimmune Therapeutics plc position in the latest Form 13F data we have. 13F covers US-listed shares held by managers with at least $100 million in such securities.
No institutional manager reported a Adaptimmune Therapeutics plc position in the latest Form 13F data we have. 13F covers US-listed shares held by managers with at least $100 million in such securities.